Rekvina Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Friday, 14th November, 2025, inter alia;1. To consider and approve Un-audited Standalone Financial Results of the Company under Indian Accounting Standards (Ind AS) for the Quarter and Half Year ended on 30th September, 2025.2. Any other agendas as may be considered necessary with the permission of the chair.Further, in accordance with the Company's Code of Conduct for Prevention of Insider Trading, the Company has intimated its 'designated persons' regarding the closure of the Trading Window for trading in the Company's equity shares from October 01, 2025 till the expiry of 48 hours from the date of said financial results are made public.
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 14Th November, 2025.
View original source (BSE India)Rekvina Laboratories Ltd. on 6ix
Story so far
Earlier from Rekvina Laboratories
- Rekvina Laboratories Ltd. Press Release Oct 13 2025
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Rekvina Laboratories Ltd. Press Release Oct 06 2025
- Announcement under Regulation 30 (LODR)-Change in Directorate
- Shareholder Meeting / Postal Ballot-Outcome of AGM
Later from Rekvina Laboratories
- Board Meeting Outcome for Outcome Of The Board Meeting Held On 14Th November, 2025
- Standalone Financial Result For The Period Ended On 30 September 2025
- Non-Applicability Of Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) (Amendment) Regulations, 2018, For The Half Year Ended On 30.09.2025.
- Rekvina Laboratories Ltd. Press Release Nov 14 2025
- Closure of Trading Window
Follow Rekvina Laboratories into a list and get an email when it puts out news.
Follow Rekvina Laboratories